Plasma osteoprotegerin levels are related to peripheral neuropathy in both types of diabetes, although the strongest relationship is in type 2, and linked to other long-term complications such as peripheral arterial disease and nephropathy [23]. Here, TNFRSF11B is linked to kidney disorder.